ClinicalTrials.gg
Status unknownNCT04986787NiBS-iCogUpdated May 25, 2023

Novel, Individualized Brain Stimulation, Network-based Approaches to Improve Cognition

An interventional study of tACS and TMS in Mild Cognitive Impairment and Healthy Aging, sponsored by Masaryk University. Status unknown at 1 site in Czechia. Open to participants aged 60 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-05-25.

Sponsored by Masaryk University · Not applicable, Interventional, and Supportive care

The sponsor has not verified this record recently (last verified May 2023), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
160
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Study summary

Impaired working memory (WM) plays a crucial role in normal aging, in mild cognitive impairment (MCI) and cognitive decline associated with dementia, such as Alzheimer's disease (AD). The aging-related differences in WM are hypothesized to be based on various neurobiological origins, for example alterations in the dynamic interplay between the large-scale brain networks have proven an important role. Recent studies have shown that non-invasive brain stimulation (NIBS) methods can modulate neuronal activity, plasticity and large-scale brain network interactions. The investigators hypothesize that multifocal NIBS can improve WM. By successive and concurrent stimulation of multiple brain regions of the WM network by transcranial alternating current stimulation (tACS) and/or repetitive transcranial magnetic stimulation (rTMS) the investigators will study dynamic interactions between distinct cortico-cortical and subcortico-cortical brain areas. By leveraging multimodal systems neuroscience information during multifocal stimulation, the investigators expect to acquire better mechanistic understand through which NIBS acts on the brain and improves cognitive functions, such as WM.

Read the detailed description

Mild cognitive impairment (MCI) describes an intermediate stage from normal cognitive functioning to dementia, and identifies a spectrum of diseases that includes impairment in both memory and non-memory cognitive domains. A deficient working memory (WM) plays a crucial role in normal aging, MCI, and cognitive decline associated with dementia, such as Alzheimer's disease (AD). WM refers to the on-line temporary storage and manipulation of information to be employed in ongoing processing, and is central to the execution of a variety of daily functions. The loss of WM efficiency related to either aging or neurodegenerative process is hypothesized to have various neurobiological roots, among which altered functioning of the fronto-parietal networks play an important role. The processing, exchange, and storing of information rely on intra- and interregional connectivity that allow neuronal populations to synchronize their firing. Based on this, intra- and cross frequency oscillatory interactions have been demonstrated as core basis for working memory processes, besides other cognitive functions. Any impairment preventing the adaptation and synchronization of the oscillatory activities within this network will inevitably lead to temporary or permanent loss of function.

In this project, based on the mentioned pathophysiological concepts, the investigators will develop and test novel, individualized, multifocal, physiology-inspired non-invasive brain stimulation (NIBS) approaches aimed at enhancing interregional processing in memory-related fronto-parieto-cerebello networks with consecutive behavioral modulation of WM processes impacting on daily life activities in aged healthy volunteers (HV) and MCI patients.

The investigators approach these aims in a step-wise manner: (1) The investigators will explore entrainment of oscillatory activity in the fronto-parietal network with transcranial alternative current stimulation (tACS) at frequencies relevant to memory encoding (theta) to boost WM in healthy seniors. (2) Then, the investigators will explore cross-frequency entrainment of interregional oscillatory interactions in the frontal and parietal target network with bifocal tACS to boost WM in healthy seniors. (3) Based on the current knowledge about the extensive involvement of the cerebellum in cognitive processes by its modulatory effects onto the fronto-parietal networks crucial for cognition, the investigators will leverage our experience in non-invasive modulation of the cerebellar outputs by means of repetitive transcranial magnetic stimulation (rTMS). rTMS over the cerebellum will be applied just before cortical entrainment to further enhance its physiological and behavioral effects. (4) Finally, the investigators will select the most effective approach from the previous work-packages to be applied in MCI patients and quantify the behavioral benefits. Besides the behavioral effects, the investigators will apply multimodal systems neuroscience approaches by means of neuroimaging (structural and functional magnetic resonance imaging; s/fMRI) and electrophysiological (Electroencephalography - EEG, transcranial magnetic stimulation - TMS) methods to determine the underlying network mechanisms and patterns of intrinsic connectivity changes. As there is significant spatial heterogeneity in fronto-parietal peak activity in healthy seniors and patients, stimulation targets will be individually defined based on fMRI. By leveraging the mechanistic aspects derived from individualized multifocal stimulation, the investigators expect to better understand the mechanisms through which NIBS techniques act on the brain and improve cognitive functions. The investigators will also test and quantify within a virtual reality (VR) task how well the intervention-driven cognitive improvement translates into daily life.

02

Conditions studied

  • Mild Cognitive Impairment
  • Healthy Aging

Keywords

  • non-invasive brain stimulation
  • tACS
  • TMS
  • cognition
  • working memory
  • MCI
  • healthy ageing
  • EEG
  • neuroimaging (MRI)
  • oscillatory activity
03

In context

Cognitive Dysfunction

3,930 studies on the registry are indexed under Cognitive Dysfunction; 1,114 are open to participants now.

This study's planned enrollment of 160 is above the median of 64 across 2,855 interventional studies indexed under Cognitive Dysfunction.

Browse Cognitive Dysfunction studies →

Lead sponsor

Masaryk University is the lead sponsor of 45 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • normal cognitive performance as assessed by a cognitive screening for healthy subjects
  • mild cognitive impairment as assessed by detailed cognitive testing ± positive AD diagnostic biomarkers for MCI subjects

Exclusion criteria

Exclusion Criteria:

  • Psychiatric disorders including major depression, major vascular lesions, or other brain pathologies that might present with cognitive decline.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Investigator)
Enrollment
160 participants (estimated)

Study arms

  • Experimental
    Entrainment with personalized bi-focal fronto-parietal synchronized tACS in HV - within-frequency

    double-blind, randomized, sham-controlled, cross-over trials assessing the effects of individualized fronto-parietal tACS on a visual working memory task in aged HV

    Device: tACS

  • Experimental
    Entrainment with personalized bi-focal fronto-parietal synchronized tACS in HV - cross-frequency

    double-blind, randomized, sham-controlled, cross-over trials assessing the effects of individualized cross-frequency fronto-parietal tACS stimulation on a visual WM task in aged HV

    Device: tACS

  • Experimental
    Cerebellar rTMS to modify the effects of cortico-cortical, fronto-parietal tACS in HV

    double-blind, randomized, sham-controlled, cross-over trial assessing the effects of cerebellar stimulation on individualized fronto-parietal tACS stimulation during a visual WM task in aged HV

    Device: tACS · Device: TMS

  • Experimental
    Neuromodulation protocol in MCI patients (precise protocol to be chosen on results of previous arms)

    double-blind, randomized, sham-controlled, cross-over trials assessing the effects of individualized striatal TIS combined with cereberal TMS on a visual working memory task in MCI patients

    Device: TMS · Device: TIS

Interventions

  • DevicetACS

    a non-invasive brain stimulation technique that allows interaction with endogenous cortical oscillatory rhythms

  • DeviceTMS

    a noninvasive procedure that uses magnetic fields to stimulate nerve cells in the brain, it will be specifically cerebellar stimulation

  • DeviceTIS

    temporal interference stimulation targeted to striatum, a non-invasive brain stimulation technique that allows interaction with endogenous cortical oscillatory rhythms deep in the brain

06

What researchers measure

Primary outcomes

  1. Working memory performance

    We will compare the baseline-normalized reaction time and error rate of a N-back task between the real and sham stimulation condition in a cross-over design.

    Time frame: through study completion, an average of 1 year

Secondary outcomes

  1. The reproducibility of the outcomes of this proof-of-concept brain stimulation in MCI between centers

    Twenty MCI patients will be recruited in each participating center. The reproducibility of the effects induced by the intervention will be assessed by comparing the baseline-normalized error rate of a N-back task between the two centers.

    Time frame: through study completion, an average of 1 year

  2. The neural underpinning of NIBS-induced changes quantified by s/fMRI and network-based analytical approaches.

    The changes in intra- and inter-regional fMRI connectivity within and between cognitive brain networks will be compared between the real and sham stimulations.

    Time frame: The changes will be computed from the difference between connectivity at baseline and 1 hour post-stimulation.

  3. The neural underpinning of NIBS-induced changes quantified by EEG.

    We will measure cortical excitability by TMS-EEG pairing via TMS-evoked potentials.

    Time frame: Baseline and 1 hour after the delivery of real or sham intervention - cross-over design.

  4. Transfer of the acquired WM abilities during the intervention into a daily-life relevant scenario as assessed by The Virtual Supermarket Shopping Task.

    The accuracy of the post-stimulation WM task in a VR-based daily life scenario as assessed by The Virtual Supermarket Shopping Task will be compared between the real or sham intervention (cross-over design).

    Time frame: through study completion, an average of 1 year

07

Study locations

1 of 1 sites recruiting
  • Ceitec Masaryk University
    Brno, 62500, Czechia
    • Lubomira Anderkova, PhD · Contact · +420 549 497 766
    Recruiting
08

References and documents

Publications

  • Saunders NL, Summers MJ. Attention and working memory deficits in mild cognitive impairment. J Clin Exp Neuropsychol. 2010 Apr;32(4):350-7. doi: 10.1080/13803390903042379. Epub 2009 Sep 25. PubMed 19787522 ↗
  • Johnson EL, Dewar CD, Solbakk AK, Endestad T, Meling TR, Knight RT. Bidirectional Frontoparietal Oscillatory Systems Support Working Memory. Curr Biol. 2017 Jun 19;27(12):1829-1835.e4. doi: 10.1016/j.cub.2017.05.046. Epub 2017 Jun 9. PubMed 28602658 ↗
  • Roux F, Uhlhaas PJ. Working memory and neural oscillations: alpha-gamma versus theta-gamma codes for distinct WM information? Trends Cogn Sci. 2014 Jan;18(1):16-25. doi: 10.1016/j.tics.2013.10.010. Epub 2013 Nov 19. PubMed 24268290 ↗
  • Kornblith S, Buschman TJ, Miller EK. Stimulus Load and Oscillatory Activity in Higher Cortex. Cereb Cortex. 2016 Sep;26(9):3772-84. doi: 10.1093/cercor/bhv182. Epub 2015 Aug 18. PubMed 26286916 ↗
  • Eldaief MC, Halko MA, Buckner RL, Pascual-Leone A. Transcranial magnetic stimulation modulates the brain's intrinsic activity in a frequency-dependent manner. Proc Natl Acad Sci U S A. 2011 Dec 27;108(52):21229-34. doi: 10.1073/pnas.1113103109. Epub 2011 Dec 12. PubMed 22160708 ↗
  • Anderkova L, Pizem D, Klobusiakova P, Gajdos M, Koritakova E, Rektorova I. Theta Burst Stimulation Enhances Connectivity of the Dorsal Attention Network in Young Healthy Subjects: An Exploratory Study. Neural Plast. 2018 Mar 13;2018:3106918. doi: 10.1155/2018/3106918. eCollection 2018. PubMed 29725346 ↗
  • Novakova L, Gajdos M, Rektorova I. Theta-burst transcranial magnetic stimulation induced cognitive task-related decrease in activity of default mode network: An exploratory study. Brain Stimul. 2020 May-Jun;13(3):597-599. doi: 10.1016/j.brs.2020.01.015. Epub 2020 Jan 31. No abstract available. PubMed 32289683 ↗
  • Plechata A, Sahula V, Fayette D, Fajnerova I. Age-Related Differences With Immersive and Non-immersive Virtual Reality in Memory Assessment. Front Psychol. 2019 Jun 11;10:1330. doi: 10.3389/fpsyg.2019.01330. eCollection 2019. PubMed 31244729 ↗

Individual participant data

Plan to share: No — Data will be shared only within both centres

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 25, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04986787
Lead sponsor
Masaryk University
Responsible party
Sponsor
First posted
Aug 3, 2021
Start date
Sep 1, 2021
Primary completion
Dec 31, 2023 (estimated)
Completion
Dec 31, 2023 (estimated)
Last update
May 25, 2023

Study contacts

Monika Pupikova
Contact
monika.pupikova@ceitec.muni.cz
+420 549 49 8313
Traian Popa
Contact
traian.popa@epfl.ch
Friedhelm C. Hummel
principal investigator · Ecole Polytechnique Fédérale de Lausanne
Irena Rektorova
principal investigator · CEITEC Masaryk University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion